Viewing nowPregabalin 150 mg Capsule
Pregabalin 150mg
Hard capsule · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

MFDS item code 201604076 · Approved 2016.06.29 · Insurance code 663607070
Treatment of peripheral and central neuropathic pain, adjunct for partial seizures in epilepsy, improvement of fibromyalgia.
This medication is used for the treatment of peripheral and central neuropathic pain in adults. It is also used as an adjunct for those experiencing partial seizures in epilepsy, effective regardless of the presence of generalized symptoms. Additionally, it helps alleviate the symptoms of fibromyalgia. This drug is extensively used for the treatment of peripheral and central neuropathic pain, partial seizures in epilepsy, and fibromyalgia.
This medication is administered as pregabalin, taken orally divided into twice daily total doses with or without food. 1. Neuropathic Pain - Peripheral Neuropathic Pain: Start with a dose of 150 mg per day. It can be increased to 300 mg per day after 3-7 days. If necessary, it may be increased to a maximum of 600 mg with an interval of 7 days. - Central Neuropathic Pain: Start with a dose of 150 mg per day. After one week, it may be increased to 300 mg per day.
This medication may increase the risk of suicidal thoughts or behaviors, so careful monitoring for abnormal changes in mood or behavior is necessary during treatment. Do not take if you have allergies to any component of this drug or certain genetic disorders such as lactose intolerance. Diabetic patients should be cautious as weight gain may require adjustment of blood sugar control medications. If symptoms of angioedema appear, immediately discontinue and consult a healthcare professional. Elderly patients should be cautious as this medication may cause dizziness or drowsiness, increasing the risk of falls. Transient blurred vision or changes in vision may occur, and if symptoms persist, consult a doctor. Abrupt discontinuation may lead to withdrawal symptoms such as insomnia, headache, and anxiety, so dosage should be gradually reduced according to a doctor's instructions. Patients with a history of substance abuse or mental disorders should be closely monitored for misuse or dependence risks with this medication. Patients with impaired renal function may require dosage adjustments and should be regularly monitored for changes in kidney function. Patients with heart disease should take this medication with caution due to the risk of cardiovascular problems such as congestive heart failure. Caution is needed if taking with other central nervous system depressants or opioid analgesics due to the risk of respiratory depression. In early pregnancy, this medication may pose a risk of congenital malformations to the fetus, therefore pregnant women should avoid taking it, and women of childbearing age should use effective contraception. If breastfeeding, this medication may be passed to the infant through breast milk, potentially affecting the infant, so it is recommended to either discontinue breastfeeding or the medication. Before engaging in potentially hazardous activities such as driving or operating machinery, ensure this medication does not cause dizziness or drowsiness. Severe skin reactions may occur, so if symptoms such as skin rash, swelling, or fever arise, immediately discontinue and consult a healthcare professional. In case of overdose, symptoms may include drowsiness, confusion, depression, seizures, and emergency treatment should be sought immediately, which may include blood dialysis if necessary. Keep this medication out of reach of children and do not transfer it to another container, as this may lead to degradation in quality or accidents.
Rash, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in the mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizure, confusion, visual disturbances, paralysis, urine issues
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect from air or moisture, and it is important to maintain a storage temperature between 15 degrees and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for a longer duration.
A capsule with a white upper and white lower part containing a powder that is white to light yellow.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.